Psychological Distress and Drug Use Patterns of Young Adult Ecstasy Users: A Complementary Analysis of Australian Datasets

REFERENCES

• Alati, R., Kinner, S. A., Hayatbakhsh, M. R., Mamun, A. A., Najman, J. M., & Williams, G. M. (2008). Pathways to ecstasy use in young adults: Anxiety depression or behavioural deviance? Drug and Alcohol Dependence, 92, 108–115.
   PubMed Web of Science ®Google Scholar
• Andrews, G., & Slade, T. (2001). Interpreting scores on the Kessler Psychological Distress Scale (K10). Australian and New Zealand Journal of Public Health, 25, 494–497.
   PubMed Web of Science ®Google Scholar
• Arnaud, B., Malet, L., Teissedre, F., Izaute, M., Moustafa, F., Geneste, J., (2010). Validity study of Kessler's Psychological Distress Scales conducted among patients admitted to French emergency department for alcohol consumption-related disorders. Alcoholism: Clinical and Experimental Research, 34, 1235–1245.
   PubMed Web of Science ®Google Scholar
• Australian Electoral Commission. (2008). Australian Electoral Commission annual report 2007–08. Canberra: Australian Electoral Commission.
   Google Scholar
• Australian Institute of Health and Welfare. (2008a). 2007 National Drug Strategy Household Survey: Detailed findings. Canberra: Australian Institute of Health and Welfare.
   Google Scholar
• Australian Institute of Health and Welfare. (2008b). 2007 National Drug Strategy Household Survey: First results. Canberra: Australian Institute of Health and Welfare.
   Google Scholar
• Baillie, A. J. (2005). Predictive gender and education bias in Kessler's Psychological Distress Scale (K10). Social Psychiatry and Psychiatric Epidemiology, 40, 743–748.
   PubMed Web of Science ®Google Scholar
• Begley, C. M. (1996). Using triangulation in nursing research. Journal of Advanced Nursing, 24, 122–128.
   PubMed Web of Science ®Google Scholar
• Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale: An updated literature review. Journal of Psychosomatic Research, 52, 69–77.
   PubMed Web of Science ®Google Scholar
• Boys, A., Farrell, M., Taylor, C., Marsden, J., Goodman, R., Brugha, T., (2003). Psychiatric morbidity and substance use in young people aged 13–15 years: Results from the Child and Adolescent Survey of Mental Health. British Journal of Psychiatry, 182, 509–517.
   PubMed Web of Science ®Google Scholar
• Breslau, N., Kilbey, M. M., & Andreski, P. (1993). Nicotine dependence and major depression: New evidence from a prospective investigation. Archives of General Psychiatry, 50, 31–35.
   PubMed Web of Science ®Google Scholar
• Chen, K., & Kandel, D. B. (1995). The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health, 85, 41–47.
   PubMed Web of Science ®Google Scholar
• Cornelius, B. L. R., Groothoff, J. W., van der Klink, J. J. L., & Brouwer, S. (2013). The performance of the K10, K6 and GHQ-12 to screen for present state DSM-IV disorders among disability claimants. BMC Public Health, 13, 128.
   PubMed Web of Science ®Google Scholar
• Costantini, M., Musso, M., Viterbori, P., Bonci, F., Del Mastro, L., Garrone, O., (1999). Detecting psychological distress in cancer patients: Validity of the Italian version of the Hospital Anxiety and Depression Scale. Supportive Care in Cancer, 7, 121–127.
   PubMed Web of Science ®Google Scholar
• Crawford, J. R., Henry, J. D., Crombie, C., & Taylor, E. P. (2001). Normative data for the HADS from a large non-clinical sample. British Journal of Clinical Psychology, 40, 429–434.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Bruno, R., & Topp, L. (2010). Is ecstasy a drug of dependence? Drug and Alcohol Dependence, 107, 1–10.
   PubMed Web of Science ®Google Scholar
• Dunbar, J. A. M. D., Reddy, P., Davis-Lameloise, N., Philpot, B., Laatikainen, T., Kilkkinen, A., (2008). Depression: An important comorbidity with metabolic syndrome in a general population. Diabetes Care, 31, 2368–2373.
   PubMed Web of Science ®Google Scholar
• Fergusson, D. M., Goodwin, R. D., & Horwood, L. J. (2003). Major depression and cigarette smoking: Results of a 21-year longitudinal study. Psychological Medicine, 33, 1357–1367.
   PubMed Web of Science ®Google Scholar
• George, J., Kinner, S. A., Bruno, R., Degenhardt, L., & Dunn, M. (2010). Contextualising psychological distress among regular ecstasy users: The importance of sociodemographic factors and patterns of drug use. Drug Alcohol Review, 29, 243–249.
   PubMedGoogle Scholar
• Griffiths, P., Vingoe, L., Hunt, N., Mounteney, J., & Hartnoll, R. (2000). Drug information systems early warning and new drug trends: Can drug monitoring systems become more sensitive to emerging trends in drug consumption? Substance Use & Misuse, 35, 811–844.
   PubMed Web of Science ®Google Scholar
• Guillot, C. (2007). Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms? Journal of Psychoactive Drugs, 39, 31–39.
   PubMed Web of Science ®Google Scholar
• Herrmann, C. (1997). International experiences with the Hospital Anxiety and Depression Scale: A review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17–41.
   PubMed Web of Science ®Google Scholar
• Hides, L., Lubman, D. I., Devlin, H., Cotton, S., Aitken, C., Gibbie, T., (2007). Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users. Australian and New Zealand Journal of Psychiatry, 41, 166–168.
   PubMed Web of Science ®Google Scholar
• Huizink, A. C., Ferdinand, R. F., van der Ende, J., & Verhulst, F. C. (2006). Symptoms of anxiety and depression in childhood and use of MDMA: Prospective, population based study. British Medical Journal, 332, 825–827.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Andrews, G., Colpe, L. J., Hiripi, E., Mroczek, D. K., Normand, S.-L. T., (2002). Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine, 32, 959–976.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., (2003). Screening for serious mental illness in the general population. Archives of General Psychiatry, 60, 184–189.
   PubMed Web of Science ®Google Scholar
• Kinner, S. A., George, J., Johnston, J., Dunn, M., & Degenhardt, L. (2012). Pills and pints: Risky drinking and alcohol-related harms among regular ecstasy users in Australia. Drug Alcohol Review, 31, 273–280.
   PubMedGoogle Scholar
• Le Strat, Y., Ramoz, N., & Gorwood, P. (2010). In alcohol-dependent drinkers what does the presence of nicotine dependence tell us about psychiatric and addictive disorders comorbidity? Alcohol and Alcoholism, 45, 167–172.
   PubMed Web of Science ®Google Scholar
• Lieb, R., Schuetz, C. G., Pfister, H., von Sydow, K., & Wittchen, H. (2002). Mental disorders in ecstasy users: A prospective-longitudinal investigation. Drug and Alcohol Dependence, 68, 195–207.
   PubMed Web of Science ®Google Scholar
• Lynskey, M. T., Heath, A. C., Bucholz, K. K., Slutske, W. S., Madden, P. A., Nelson, E. C., (2003). Escalation of drug use in early-onset cannabis users vs co-twin controls. Journal of the American Medical Association, 289, 427–433.
   PubMed Web of Science ®Google Scholar
• Measham, F. (2004). The decline of ecstasy, the rise of “binge” drinking and the persistence of pleasure. Probation Journal, 51, 309–326.
   Google Scholar
• Miller, P. G., Johnston, J., Dunn, M., Fry, C. L., & Degenhardt, L. (2010). Comparing probability and non-probability sampling methods in ecstasy research: Implications for the Internet as a research tool. Substance Use and Misuse, 45, 437–450.
   PubMed Web of Science ®Google Scholar
• Morral, A. R., McCaffrey, D. F., & Paddock, S. M. (2002). Reassessing the marijuana gateway effect. Addiction, 97, 1493–1504.
   PubMed Web of Science ®Google Scholar
• Mounteney, J., Fry, C., McKeganey, N., & Haugland, S. (2010). Challenges of reliability and validity in the identification and monitoring of emerging drug trends. Substance Use & Misuse, 45, 266–287.
   PubMed Web of Science ®Google Scholar
• Newcomb, M. D., Vargas-Carmona, J., & Galaif, E. R. (1999). Drug problems and psychological distress among a community sample of adults: Predictors, consequences, or confound? Journal of Community Psychology, 27, 405–429.
   Web of Science ®Google Scholar
• Orlando, M., Ellickson, P. L., & Jinnett, K. (2001). The temporal relationship between emotional distress and cigarette smoking during adolescence and young adulthood. Journal of Consulting and Clinical Psychology, 69, 959–970.
   PubMed Web of Science ®Google Scholar
• Patton, G. C., Carlin, J. B., Coffey, C., Wolfe, R., Hibbert, M., & Bowes, G. (1998). Depression anxiety and smoking initiation: A prospective study over 3 years. American Journal of Public Health, 88, 1518–1522.
   PubMed Web of Science ®Google Scholar
• Pletcher, J. R., & Schwarz, D. F. (2000). Current concepts in adolescent smoking. Current Opinion in Pediatrics, 12, 444–449.
   PubMedGoogle Scholar
• Rogers, G., Elston, J., Garside, R., Roome, C., Taylor, R., Younger, P., (2009). The harmful health effects of recreational ecstasy: A systematic review of observational evidence. Health Technology Assessment, 13, iii-iv, ix-xii, 1–315.
   Web of Science ®Google Scholar
• Scott, R. M., Hides, L., Allen, J. S., Burke, R., & Lubman, D. (2010). Depressive and anxiety symptomatology in ecstasy users: The relative contribution of genes trauma life stress and drug use. Psychopharmacology, 209, 25–36.
   PubMedGoogle Scholar
• Sindicich, N., & Burns, L. (2010). Australian trends in ecstasy and related drug markets 2009: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Sydney: N.S.W. National Drug and Alcohol Research Centre, University of NSW.
   Google Scholar
• Slade, T., Grove, R., & Burgess, P. (2011). Kessler Psychological Distress Scale: Normative data from the 2007 Australian National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry, 45, 308–316.
   PubMed Web of Science ®Google Scholar
• Spinhoven, P., Ormel, J., Sloekers, P. P., Kempen, G. I., Speckens, A. E., & Van Hemert, A. M. (1997). A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychological Medicine, 27, 363–370.
   PubMed Web of Science ®Google Scholar
• Spooner, C. (1999). Causes and correlates of adolescent drug abuse and implications for treatment. Drug and Alcohol Review, 18, 453–475.
   Web of Science ®Google Scholar
• Sumnall, H. R., & Cole, J. C. (2005). Self-reported depressive symptomatology in community samples of polysubstance misusers who report ecstasy use: A meta-analysis. Journal of Psychopharmacology, 19, 84–92.
   PubMed Web of Science ®Google Scholar
• Topp, L., Barker, B., & Degenhardt, L. (2004). The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug and Alcohol Dependence, 73, 33–40.
   PubMed Web of Science ®Google Scholar
• Topp, L., Breen, C., Kaye, S., & Darke, S. (2004). Adapting the Illicit Drug Reporting System (IDRS) to examine the feasibility of monitoring trends in the markets for “party drugs.” Drug and Alcohol Dependence, 73, 189–197.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. (2010). World drug report 2010. New York: Author.
   Google Scholar
• Verheyden, S. L., Henry, J. A., & Curran, H. V. (2003). Acute, sub-acute and long-term subjective consequences of “ecstasy” (MDMA) consumption in 430 regular users. Human Psychopharmacology, 18, 507–517.
   PubMed Web of Science ®Google Scholar
• von Sydow, K., Lieb, R., Pfister, H., Hofler, M., & Wittchen, H. U. (2002). Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults: A transient phenomenon? Results from a longitudinal community study. Drug and Alcohol Dependence, 66, 147–159.
   PubMed Web of Science ®Google Scholar